The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 1st 2025
New multicenter research suggests that radiomic features derived from breast MRI may enhance prognostic capabilities with disease upstaging for ductal carcinoma in situ (DCIS).
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment
April 4, 2025 | New York, NY & Virtual
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
Can Combination of mpMRI and Extracellular Vesicle-Based Biomarkers Enhance csPCa Detection?
January 29th 2024A multivariable model that includes mpMRI and blood testing assessment of prostate extracellular vesicles had a significantly higher AUC and sensitivity rate than mpMRI alone for predicting clinically significant prostate cancer, according to research presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU).
Study Shows BPE Quantification on MRI Helps Predict Risk of Breast Cancer Recurrence
January 24th 2024Researchers found that several measurements of background parenchymal enhancement (BPE) on dynamic contrast-enhanced MRI were linked to a 27 to 66 percent higher risk of breast cancer recurrence.
Key Takeaways from Multiple Radiology Societies on AI Assessment and Integration
January 22nd 2024In a recently issued statement from multiple radiology societies including the RSNA and ACR, researchers offer practical advice for evaluating artificial intelligence (AI) tools, implementing AI into current workflows and monitoring of the technology to help ensure optimal benefit and effectiveness.
Claustrophobia in Magnetic Resonance Imaging: An Analysis of Causes, Impacts and Solutions
January 18th 2024Given the frequent challenges in magnetic resonance imaging that are associated with claustrophobia, this author discusses innovations in noise reduction, radiofrequency coils and wide bore scanners, and emphasizes keys to relieving patient anxiety.
Newly FDA-Cleared Stereotactic System Can be Utilized with Pre-Op MRI or CT
January 17th 2024Utilized for neurological procedures including biopsies, catheter placement and electrode introduction, the SmartFrame OR Stereotactic System can be combined with preoperative MRI or CT to ensure optimal placement of devices and instruments.
Study: Abbreviated MRI and DBT Offer Comparable Breast Cancer Detection in Dense Breasts
January 17th 2024For women with dense breasts, abbreviated breast MRI and digital breast tomosynthesis (DBT) both offered greater than 98 percent sensitivity rates and greater than 94 percent negative predictive values (NPVs) for breast cancer detection, according to newly published research.
Hybrid MRI Deep Learning Model Shows Promise in Predicting Tumor Deposits with Rectal Cancer
January 3rd 2024An emerging deep learning model, which incorporates T2-weighted MRI and clinical data, demonstrated an 83.9 percent AUC and an 85 percent specificity rate for preoperative prediction of tumor deposits in patients with rectal cancer.
Can ChatGPT and Bard Bolster Decision-Making for Cancer Screening in Radiology?
December 21st 2023In a study examining the potential of the large language models ChatGPT-4 and Bard to follow ACR Appropriateness Criteria for breast cancer, lung cancer, ovarian cancer and colorectal cancer screening, researchers noted “impressive accuracy in making radiologic clinical decisions.”
Is Contrast-Enhanced Mammography a Viable Option for Diagnosing Invasive Lobular Carcinoma?
December 15th 2023Contrast-enhanced mammography had a 98 percent sensitivity rate for diagnosing invasive lobular carcinoma and provided high conspicuity for 82 percent of detected lesions, according to research presented at the recent Radiological Society of North America (RSNA) conference.